Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan.

The purpose of this research was to develop polylactic-co-glycolic acid (PLGA) nanospheres surface modified with chitosan (CS). Mitoxantrone- (MTO-) loaded PLGA nanospheres were prepared by a solvent evaporation technique. The PLGA nanospheres surface was modified with CS by two strategies (adsorption and covalent binding). PLGA nanospheres of 248.4+/-21.0 nm in diameter characterized by the laser light scattering technique, scanning electron microscopy (SEM) are spherical and its drug encapsulation efficiency is 84.1+/-3.4%. Zeta potential of unmodified nanospheres was measured to be negative -21.21+/-2.13 mV. The positive zeta potential of modified nanospheres reveals the presence of CS on the surface of the modified nanospheres. Modified nanospheres were characterized for surface chemistry by X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FT-IR). FT-IR spectra exhibited peaks at 3420 cm(-1) and 1570 cm(-1), XPS spectra shows the N 1s (atomic orbital 1s of nitrogen) region of the surface of the nanospheres, corresponding to the primary amide of CS. In vitro drug release demonstrated that CS-modified nanospheres have many advantages such as prolonged drug release property and decreased the burst release over the unmodified nanospheres, and the modified nanospheres by covalent binding method could achieve the release kinetics of a relatively constant release. These data demonstrate high potential of CS-modified PLGA nanospheres for the anticancer drug carrier.

[1]  Richard A Gemeinhart,et al.  Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  Tao Wang,et al.  Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. , 2005, Colloids and surfaces. B, Biointerfaces.

[3]  Tae Woo Kim,et al.  A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. , 2008, International journal of pharmaceutics.

[4]  Y Wang,et al.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Janko Kos,et al.  Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[6]  U. Bakowsky,et al.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.

[7]  S. Vyas,et al.  Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. , 2006, Vaccine.

[8]  S. Antimisiaris,et al.  PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. , 2008, Colloids and surfaces. B, Biointerfaces.

[9]  Keishiro Tomoda,et al.  Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles. , 2008, Colloids and surfaces. B, Biointerfaces.

[10]  Pushpa Mishra,et al.  Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[11]  B. Gander,et al.  The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. , 2007, Biomaterials.

[12]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[13]  L. Lim,et al.  Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Dae-Duk Kim,et al.  Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. , 2009, International journal of pharmaceutics.

[15]  Shohei Sugimoto,et al.  Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[16]  P. Smith,et al.  Subcellular distribution of the anticancer drug mitoxantrone in human and drug-resistant murine cells analyzed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage. , 1992, Cancer research.

[17]  P. Perugini,et al.  Periodontal delivery of ipriflavone: new chitosan/PLGA film delivery system for a lipophilic drug. , 2003, International journal of pharmaceutics.

[18]  Multi-functional nanoparticles for cancer therapy , 2007 .

[19]  Zhi‐Kang Xu,et al.  Adsorption and activity of lipase from Candida rugosa on the chitosan-modified poly(acrylonitrile-co-maleic acid) membrane surface. , 2007, Colloids and surfaces. B, Biointerfaces.

[20]  Zi-rong Xu,et al.  In vivo antitumor activity of chitosan nanoparticles. , 2006, Bioorganic & medicinal chemistry letters.

[21]  Hong Yang,et al.  Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: Formulation and in vitro characterization. , 2006, International journal of pharmaceutics.

[22]  Si-Shen Feng,et al.  Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. , 2007, Biomaterials.

[23]  Anubhav Jain,et al.  Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. , 2005, International journal of pharmaceutics.

[24]  T. Chung,et al.  Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. , 2008, Biomaterials.

[25]  Y. Kawashima,et al.  Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. , 2008, International journal of pharmaceutics.

[26]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Lingrong Liu,et al.  Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin , 2007 .

[28]  T. Delair,et al.  Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties. , 2005, Colloids and surfaces. B, Biointerfaces.

[29]  M. Kurisawa,et al.  Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. , 2007, Biomaterials.

[30]  Jianqing Gao,et al.  A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres. , 2004, Biochemical and biophysical research communications.

[31]  B. Gander,et al.  One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Peter Fredericks,et al.  Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. , 2007, Biomacromolecules.

[33]  C. Dass,et al.  Injectable chitosan hydrogels for localised cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[34]  W. J. Wang,et al.  Covalent immobilization of chitosan and heparin on PLGA surface. , 2003, International journal of biological macromolecules.